Fig. 3From: Classification of PR-positive and PR-negative subtypes in ER-positive and HER2-negative breast cancers based on pathway scoresClassifying ER+/PR + and ER+/PR- using 1387 pathways with LASSO methodology a Plots for LASSO regression coefficients over different values of the penalty parameter. b Cross-validation plot for the penalty term. c Receiver operating characteristic curve of the final modelBack to article page